BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 30907673)

  • 1. Advances in prognostic markers for colorectal cancer
    Duan L; Yang W; Wang X; Zhou W; Zhang Y; Liu J; Zhang H; Zhao Q; Hong L; Fan D
    Expert Rev Mol Diagn; 2019 Apr; 19(4):313-324. PubMed ID: 30907673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive and prognostic biomarkers in colorectal cancer: A systematic review of recent advances and challenges.
    Das V; Kalita J; Pal M
    Biomed Pharmacother; 2017 Mar; 87():8-19. PubMed ID: 28040600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and epigenetic markers in colorectal cancer screening: recent advances.
    Singh MP; Rai S; Suyal S; Singh SK; Singh NK; Agarwal A; Srivastava S
    Expert Rev Mol Diagn; 2017 Jul; 17(7):665-685. PubMed ID: 28562109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer.
    Coppedè F; Lopomo A; Spisni R; Migliore L
    World J Gastroenterol; 2014 Jan; 20(4):943-56. PubMed ID: 24574767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and molecular origins of colorectal Cancer among the Iranians: an update.
    Abbaszadegan MR; Moghbeli M
    Diagn Pathol; 2018 Dec; 13(1):97. PubMed ID: 30579343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives on new biomarkers in gastric cancer: diagnostic and prognostic applications.
    Pinheiro Ddo R; Ferreira WA; Barros MB; Araújo MD; Rodrigues-Antunes S; Borges Bdo N
    World J Gastroenterol; 2014 Sep; 20(33):11574-85. PubMed ID: 25206265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteogenomic biomarkers in colorectal cancers: clinical applications.
    Binetti M; Lauro A; Vaccari S; Cervellera M; Tonini V
    Expert Rev Proteomics; 2020 May; 17(5):355-363. PubMed ID: 32536221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic biomarkers in colorectal cancer: premises and prospects.
    Zamani M; Hosseini SV; Mokarram P
    Biomarkers; 2018 Mar; 23(2):105-114. PubMed ID: 27788596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic Biomarkers in Colorectal Cancer.
    Verma M; Kumar V
    Mol Diagn Ther; 2017 Apr; 21(2):153-165. PubMed ID: 27878475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and epigenetic marker-based DNA test of stool is a promising approach for colorectal cancer screening.
    An SW; Kim NK; Chung HC
    Yonsei Med J; 2009 Jun; 50(3):331-4. PubMed ID: 19568592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in epigenetic biomarker research in colorectal cancer.
    Wang X; Kuang YY; Hu XT
    World J Gastroenterol; 2014 Apr; 20(15):4276-87. PubMed ID: 24764665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review.
    Draht MXG; Goudkade D; Koch A; Grabsch HI; Weijenberg MP; van Engeland M; Melotte V; Smits KM
    Clin Epigenetics; 2018; 10():35. PubMed ID: 29564023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of MicroRNAs as Potential Diagnostic and Prognostic Markers in Colorectal Cancer.
    Hibner G; Kimsa-Furdzik M; Francuz T
    Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30262723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRC-113 gene expression signature for predicting prognosis in patients with colorectal cancer.
    Nguyen MN; Choi TG; Nguyen DT; Kim JH; Jo YH; Shahid M; Akter S; Aryal SN; Yoo JY; Ahn YJ; Cho KM; Lee JS; Choe W; Kang I; Ha J; Kim SS
    Oncotarget; 2015 Oct; 6(31):31674-92. PubMed ID: 26397224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assimilating Epigenetics and Transcriptomics for the Identification of Prognostic Novel Biomarkers and Imminent Targets in Colorectal Carcinoma with Therapeutic Potential.
    Ray SK; Mukherjee S
    Curr Mol Med; 2023; 23(8):784-798. PubMed ID: 35546765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New trends in molecular and cellular biomarker discovery for colorectal cancer.
    Aghagolzadeh P; Radpour R
    World J Gastroenterol; 2016 Jul; 22(25):5678-93. PubMed ID: 27433083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Molecular Subtypes in Optimizing Personalized Therapy for Metastatic Colorectal Cancer.
    Włodarczyk M; Włodarczyk J; Siwiński P; Sobolewska-Włodarczyk A; Fichna J
    Curr Drug Targets; 2018; 19(15):1731-1737. PubMed ID: 30073926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic Biomarkers in Colorectal Cancer Patients Receiving Adjuvant or Neoadjuvant Therapy: A Systematic Review of Epidemiological Studies.
    Barchitta M; Maugeri A; Li Destri G; Basile G; Agodi A
    Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31390840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic Alteration in Colorectal Cancer: Potential Diagnostic and Prognostic Implications.
    Cao Q; Tian Y; Deng Z; Yang F; Chen E
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translating colorectal cancer genetics into clinically useful biomarkers.
    Morley-Bunker A; Walker LC; Currie MJ; Pearson J; Eglinton T
    Colorectal Dis; 2016 Aug; 18(8):749-62. PubMed ID: 26990814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.